Vascular occlusions in COVID-19: a case series

Czech version

Authors: Vojtěch Mezera ¹; Anicet Mahumon Ulrich Kanhounnon ²
Authors‘ workplace: Geriatrické centrum, Pardubická nemocnice ¹; Kardiologické oddělení, Pardubická nemocnice ²
Published in: Geriatrie a Gerontologie 2021, 10, č. 4: 233-236
Category:

Overview

COVID-19 is associated with a high risk of venous thromboembolism. In addition, cases of arterial thromboembolism were also reported. Here, we report three different patients developing arterial and venous thromboses during COVID-19. Interestingly, the most hidden thrombosis was the only one with a good outcome.

Keywords:

COVID-19 – acute limb ischemia – deep venous thrombosis – arterial occlusion

Sources

1. Klok FA, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145–147.

2. Chen T, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: 1091.

3. Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020; 120(6): 949–956.

4. Diaz JV. Clinical management of COVID-19: interim guidance. World Health Organization 2020. May, 1–62.

5. Paranjpe I, et al. Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. J Am Coll Cardiol 2020; 76(1): 122–124.

6. Escalard S, et al. Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris. Stroke 2020; 51(8): 2540–2543.

7. Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest 2020; 130(8): 3950–3953.

8. Zuo Y, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 2020; 12(570): 3876.

9. El Shamy O, et al. Bilateral Renal Artery Thrombosis in a Patient With COVID-19. Kidney Med 2021; 3: 116–119.

10. Zhang L, et al. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost 2020; 18(6): 1324–1329.

11. Maldonado E, et al. Antithrombotic Therapies in COVID-19 Disease: a systematic review. J Ger Intern Med 2020; 35(9): 2698–2706.

12. Gupta N, et al. The stimulation of thrombosis by hypoxia. Thromb Res Sep 2019; 181: 77–83.

13. Barbar S, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8(11): 2450–2457.

14. Česká společnost pro trombózu a hemostázu. Antitrombotická profylaxe u nemocných s COVID-19. Doporučený postup České společnosti pro trombózu a hemostázu ČLS JEP.

15. Chow JH, et al. Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19. Anesth Analg; 2021 Apr 1;132(4):930–941.

16. Česká společnost pro trombózu a hemostázu. Stanovisko výboru ČSTH k problematice očkování proti infekci COVID-19 očkovací látkou firmy AstraZeneca. Antitrombotická profylaxe u nemocných s COVID-19. (2021).